Literature DB >> 26703854

Encapsulating Peritoneal Sclerosis In a Kidney Graft Recipient Unmasked by Everolimus Switch.

Agnieszka A Pozdzik1, Vasco Fernandez2, Pieter Demetter3, Monika Tooulou4, Celso Matos5, Nadia Gammar4, Nilufer Broeders4, Max Dratwa6, Joëlle Nortier4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26703854      PMCID： PMC4690640          DOI： 10.3747/pdi.2014.00157

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN： 0896-8608            Impact factor:   1.756


× No keyword cloud information.
  7 in total

1.  Development of encapsulating peritoneal sclerosis in a renal transplant recipient on sirolimus immunotherapy.

Authors:  S Temple; J Zaltzman; J Perl
Journal:  Perit Dial Int       Date:  2010 Jul-Aug       Impact factor: 1.756

2.  Posttransplantation encapsulating peritoneal sclerosis contributes significantly to mortality after kidney transplantation.

Authors:  M R Korte; S M Habib; H Lingsma; W Weimar; M G H Betjes
Journal:  Am J Transplant       Date:  2011-02-07       Impact factor: 8.086

3.  Initial observations using a novel "cine" magnetic resonance imaging technique to detect changes in abdominal motion caused by encapsulating peritoneal sclerosis.

Authors:  Benjamin Wright; Angela Summers; John Fenner; Richard Gillott; Charles E Hutchinson; Paul A Spencer; Martin Wilkie; Helen Hurst; Sarah Herrick; Paul Brenchley; Titus Augustine; Karna D Bardhan
Journal:  Perit Dial Int       Date:  2011-03-31       Impact factor: 1.756

4.  Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes.

Authors:  David W Johnson; Yeoungjee Cho; Brian E R Livingston; Carmel M Hawley; Stephen P McDonald; Fiona G Brown; Johan B Rosman; Kym M Bannister; Kathryn J Wiggins
Journal:  Kidney Int       Date:  2010-03-10       Impact factor: 10.612

5.  Everolimus-induced lymphedema in a renal transplant recipient: a case report.

Authors:  Alparslan Ersoy; Nizameddin Koca
Journal:  Exp Clin Transplant       Date:  2012-06       Impact factor: 0.945

6.  Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis.

Authors:  S Huber; C J Bruns; G Schmid; P C Hermann; C Conrad; H Niess; R Huss; C Graeb; K-W Jauch; C Heeschen; M Guba
Journal:  Kidney Int       Date:  2007-02-14       Impact factor: 10.612

7.  Effects of everolimus as an antiproliferative agent on regression of encapsulating peritoneal sclerosis in a rat model.

Authors:  Soner Duman; Devrim Bozkurt; Savas Sipahi; Murat Sezak; Sultan Ozkan; Muhittin Ertilav; Sait Sen; Ercan Ok
Journal:  Adv Perit Dial       Date:  2008
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.